Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

Trump’s executive order will stifle pharmaceutical innovation, raise costs and endanger patients’ lives.

“For years, pharmaceutical and drug companies have said that research and development costs were what they are, and for no reason whatsoever, they had to be borne by America alone,” Trump said ...

There are many problems with the plan. For instance, it ignores the fact that generic drugs, which make up 90% of ...

WASHINGTON (AP) — President Donald Trump’s plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he’s even signed ...

"It would mean less treatments and cures and would jeopardize the hundreds of billions our member companies are planning to invest in America ... The pharmaceutical industry argued that Trump ...

Donald Trump has signed an executive order, described as a “game changer”, which could hit Australia harder than any of his other moves since taking office.